Nykredit A/S’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Nykredit A/S's RYTM Position: Q3 2026 in Review
Nykredit A/S held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 2,525 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #950.
Nykredit A/S first reported a position in RYTM in Q2 2026 and has held it in 2 quarters since. The position peaked at $280K in Q2 2026. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Nykredit A/S held 2,525 shares of Rhythm Pharmaceuticals worth $240K as of Q3 2026.
- Nykredit A/S left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q3 2026, its #950 holding.
- Nykredit A/S first reported a position in Rhythm Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Nykredit A/S's Rhythm Pharmaceuticals position peaked at $280K in Q2 2026.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.